Evidence map›Paper›PMID 30949763›Full record

SynthesisMedical microbiology and immunology2019

Effect of latent cytomegalovirus infection on the antibody response to influenza vaccination: a systematic review and meta-analysis.

S P H van den Berg, K Warmink, J A M Borghans, M J Knol, D van Baarle

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Medical microbiology and immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Cytomegalovirus and Aging-How Can the Field Move Forward?The Journal of infectious diseases · 2026
    Article
  3. Article
  4. A viral glycoprotein targets IgGEMBO molecular medicine · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. A vaccine against cytomegalovirus: how close are we?The Journal of clinical investigation · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Impaired CD4Nature aging · 2023
    Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S P H van den BergCentre for Infectious Disease Control, Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.ORCID http://orcid.org/0000-0002-2113-4732
K WarminkCentre for Infectious Disease Control, Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
J A M BorghansLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
M J KnolCentre for Infectious Disease Control, Epidemiology and Surveillance Unit, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
D van BaarleCentre for Infectious Disease Control, Immunology of Infectious Diseases and Vaccines, National Institute for Public Health and the Environment, Bilthoven, The Netherlands. debbie.van.baarle@rivm.nl.
University Medical Center Utrecht · NLNational Institute for Public Health and the Environment · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Latent infection with cytomegalovirus (CMV) is thought to accelerate aging of the immune system. With age, influenza vaccine responses are impaired. Although several studies investigated the effect of CMV infection on antibody responses to influenza vaccination, this led to contradicting conclusions. Therefore, we investigated the relation between CMV infection and the antibody response to influenza vaccination by performing a systematic review and meta-analysis. All studies on the antibody response to influenza vaccination in association with CMV infection were included (n = 17). The following outcome variables were extracted: (a) the geometric mean titer pre-/post-vaccination ratio (GMR) per CMV serostatus group, and in addition (b) the percentage of subjects with a response per CMV serostatus group and (c) the association between influenza- and CMV-specific antibody titers. The influenza-specific GMR revealed no clear evidence for an effect of CMV seropositivity on the influenza vaccine response in young or old individuals. Meta-analysis of the response rate to influenza vaccination showed a non-significant trend towards a negative effect of CMV seropositivity. However, funnel plot analysis suggests that this is a consequence of publication bias. A weak negative association between CMV antibody titers and influenza antibody titers was reported in several studies, but associations could not be analyzed systematically due to the variety of outcome variables. In conclusion, by systematically integrating the available studies, we show that there is no unequivocal evidence that latent CMV infection affects the influenza antibody response to vaccination. Further studies, including the level of CMV antibodies, are required to settle on the potential influence of latent CMV infection on the influenza vaccine response.

Indexed as

Antibody FormationVirus LatencyAntibodies, ViralCytomegalovirusCytomegalovirus InfectionsHumansImmunosenescenceInfluenza VaccinesOrthomyxoviridaeAntibodies, ViralInfluenza VaccinesAgeAntibody responseCytomegalovirusImmunosenescenceInfluenzaVaccine

Identifiers

PMID30949763
PMCPMC6647367
OpenAlexW2927160314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.